Your browser doesn't support javascript.
loading
Intravitreal bevacizumab associated with photodynamic therapy in a case of polypoidal choroidal vasculopathy associated with choroidal nevus: A case report.
Rangel, Carlos M; Villota, Eva; Fernández-Vega González, Álvaro; Sanchez-Avila, Ronald M.
Affiliation
  • Rangel CM; Instituto Universitario Fernández-Vega, Fundación de Investigación Oftalmológica, Oviedo, Spain Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia.
Medicine (Baltimore) ; 96(52): e9400, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29384917
ABSTRACT
RATIONALE Report the clinical findings and management of a case of polypoidal choroidal vasculopathy associated with choroidal nevus which received combination therapy. PATIENT CONCERNS Decreased visual acuity in a woman with polypoidal choroidal vasculopathy and choroidal nevus. DIAGNOSES Polypoidal choroidal vasculopathy and choroidal nevus.

INTERVENTIONS:

The initial visual acuity was 0.5. After the first treatment with photodynamic therapy, exudation and bleeding appeared around the lesion. After this, the patient received 3 doses of intravitreal bevacizumab.

OUTCOMES:

After treatment with combination therapy, visual acuity, clinical and imaging findings improved, with no recurrence of exudation and bleeding. LESSONS Intravitreal bevacizumab as an adjunctive treatment after photodynamic therapy is a good option for patients with polypoidal choroidal vasculopathy associated with choroidal nevus.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Choroid Neoplasms / Choroidal Neovascularization / Angiogenesis Inhibitors / Bevacizumab / Nevus Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Choroid Neoplasms / Choroidal Neovascularization / Angiogenesis Inhibitors / Bevacizumab / Nevus Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2017 Document type: Article Affiliation country:
...